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1. Summary
MuRF1 is an E3 ubiquitin ligase central to muscle catabolism. It belongs to the
TRIM protein family characterized by a tripartite fold of RING, B-box and
coiled-coil (CC) motifs, followed by variable C-terminal domains. The CC
motif is hypothesized to be responsible for domain organization in the fold as
well as for high-order assembly into functional entities. But data on CC from
this family that can clarify the structural significance of this motif are scarce.
We have characterized the helical region from MuRF1 and show that, contrary
to expectations, its CC domain assembles unproductively, being the B2- and
COS-boxes in the fold (respectively flanking the CC) that promote a native qua-
ternary structure. In particular, the C-terminal COS-box seemingly forms an
a-hairpin that packs against the CC, influencing its dimerization. This shows
that a C-terminal variable domain can be tightly integrated within the conserved
TRIM fold to modulate its structure and function. Furthermore, data from trans-
fected muscle show that in MuRF1 the COS-box mediates the in vivo targeting of
sarcoskeletal structures and points to the pharmacological relevance of the COS
domain for treating MuRF1-mediated muscle atrophy.
& 2014 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original
author and source are credited.
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2. Background
The regulation of protein catabolism by the proteasome
system receives ever-increasing attention owing to its
impact on the (patho)physiology of the eukaryotic cell. The
TRIM protein family consists of E2 and E3 ubiquitylating pro-
teins that arbitrate cellular processes, such as growth and
differentiation, transcription, apoptosis and viral response
[1,2]. Consequently, TRIMs have been linked to multiple
pathologies, including cancer, familiar Mediterranean fever,
Opitz/BBB syndrome, mulibrey nanism, thyroid carcinomas
and myopathy [3–6]. Despite their functional diversity,
TRIM proteins invariably share a tripartite fold consisting
of a RING finger (R), one or two RING finger-like B-box
domains (B) and a helical segment predicted to form a
coiled-coil (CC) motif. This RBCC fold constitutes the con-
stant N-terminal fraction of TRIM proteins, but variable
domains can be found in C-terminal position (e.g. PHD,
COS-box, PRY-SPRY). Those specific domains define the
classification of the more than 70 members of the TRIM
family into nine distinct classes (CI-CIX, where C signifies
C-terminal subgroup) [7,8].
The function of the TRIM/RBCC fold is to serve as a scaf-
fold that induces homo- and heteromeric interactions across
diverse E2–E3 ubiquitylation systems, leading to their for-
mation of pleiotropic complexes in the cell [2,9,10]. The CC
domain is thought to be central to this function by contribut-
ing to position domains within the TRIM fold, promoting
high-order assembly and mediating molecular targeting.
However, CC domains from TRIMs have atypical sequences
with poorly defined heptad-repeat compositions that confer
on them complex associative properties and a pronounced
tendency to aggregate. This hinders their characterization at
the molecular level and, as a result, little understanding
exists of their self-assembly process.
Muscle-specific RING fingers proteins (MuRFs) are E3 ubi-
quitin ligases that associate with the sarcomeric cytoskeleton
reportedly through their CC domains [11]. MuRFs form the
C-II TRIM class [7], whose C-terminal specific fraction contains
a COS (C-terminal subgroup One Signature)-box motif and an
intrinsically disordered acidic tail (figure 1). There are three
known members of the MuRF family—MuRF1 [12], MuRF2
[13] and MuRF3 [14]—all involved in controlling the trophicity
of striated muscle tissue. The three MuRFs are encoded by
different genes but are remarkably conserved: approximately
81% sequence identity across their RB fractions and approxi-
mately 36% in their CC domains [6]. MuRF1 is the
best-studied member of the family. It is strongly upregulated
by atrophic stimuli, such as immobilization, denervation,
nutritional deprivation, ageing and disease (e.g. cancer,
sepsis and renal failure) [15–17]. MuRF1 targets components
of the contractile sarcoskeleton; namely, myosin [18,19], tropo-
nin-T and titin [12,20,21]. Thus, it is regarded as the critical E3
ligase that acts on the cytoskeleton in situ, contributing to the
disassembly of the myofibril. MuRF1 also appears to have sig-
nalling roles in the cell as it interacts with a broad range of
cellular factors, including ubiquitin carboxyl-terminal hydro-
lase 13 (USP13), the SUMO E2 ligase Ubc9 and the
transcription regulator GMEB-1 [22]. MuRF1 deletion attenu-
ates muscle wasting and it is a pursued pharmacological
target [15,23]. Despite this, the structural and functional differ-
ences between MuRFs are poorly understood, as is the balance
of their expression across muscle types and during develop-
ment [24,25]. MuRF2 and MuRF3 are not transcriptionally
upregulated by atrophic stimuli, but they act synergistically
with MuRF1 (e.g. myosin is co-degraded by MuRF1 and
MuRF3 [26],whileMuRF1 andMuRF2 jointlymodulate cardiac
hypertrophy by acting on CARP/EEF1G [21]). Such functional
couplingmight reflect the formation ofMuRF hetero-oligomers
in the cell, as is characteristic of TRIM proteins.
The molecular understanding of MuRF1 targeting is
scarce, with only the interaction with the titin myofilament
having been studied in vitro [11,12]. Using recombinant
samples, we showed that MuRF1 binds M-line titin with
high affinity through its helical domain (HD) [11]. The binding
site in titin is formed by a tandem of Ig-Ig-Fn domains (A168-
A170) just N-terminal to titin kinase. We previously character-
ized this tandem structurally at atomic level and identified the
determinants of its binding [11]. By contrast, little is known
about the structure of MuRF1 and its CC scaffold, which is
central to molecular targeting. Here, we study the full-length
HD of MuRF1, spanning its atypical CC sequence and the
COS-box flanking domain. Our data reveal the interrelation
of these motifs both structurally and functionally within the
TRIM fold of MuRF1, and, in particular, the high significance
of the COS-box in sarcomere targeting.
3. Results
3.1. The helical domain of MuRF1 has low propensity
to coiled-coil formation
To estimate the associative properties of the HDs of MuRFs,
we predicted their potential for CC formation. CC motifs con-
sist of two to five amphipathic a-helices that wind around
each other to form, typically, a left-handed supercoil, thereby
inducing protein oligomerization [27]. CC sequences are
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Figure 1. Schematic domain composition of MuRF1. MFC refers to an MuRF family specific motif, and AT denotes a C-terminal acidic tail, which is predicted to be
unstructured. Constructs used in this study are indicated.
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characterized by a heptad-repeat of amino acids denoted by a
to g. Positions a and d classically harbour hydrophobic
residues, which constitute the structural core of the motif.
Positions e and g often host charged groups that form intra-
and inter-helical salt bridges crucial to fold stability and
interchain registry. An initial prediction of secondary struc-
ture content indicated that the helical region of MuRFs
consists of a long, uninterrupted helix (helix H1), followed
by two short C-terminal helices (helix H2 and H3) linked
by loops and mapping to the COS-box motif (figure 2).
This prediction is consistent with a previous study that esti-
mated the secondary structure content of the helical region
of MuRF1 to be 70% a-helix and 30% random coil, based
on circular dichroism data [11]. Predictors indicated that
only the C-terminal end of the long helix H1 is compatible
with CC formation. The prediction was consistent for all
three MuRFs, although MuRF2 had the shortest predicted
CC-segment owing to the presence of bulky residues (M227
and F266) in core heptad positions a and d. Such groups are
poorly accommodated in the limited interface of coilinga-helices
[28]. The tendency for CC formation was modest for all MuRFs,
as reflected by the low probability scores (figure 2c). The scores,
in addition, could not resolve a preference for dimeric or trimeric
association as both states yielded comparable probability
values. However, previous studies that used size exclusion
chromatography coupled to multi-angle laser light scattering
(SEC-MALLS) on the helical fraction of MuRF1 showed it to
form dimers [11,29]. In the light of these data, the predictions
led us to anticipate that the CC-prone, C-terminal end of helix
H1 must form dimeric CC motifs, thereby being a molecular
determinant of self-assembly in MuRFs.
3.2. Crystal structure of the MuRF1 CC segment reveals
a tetrameric palindrome
To gain an insight into the assembly of the CC-prone segment
identified, we elucidated the crystal structure of the corre-
sponding fragment from human MuRF1 (MuRF1CC) to
2.1 A˚ resolution (table 1). The crystals contained four copies
of the MuRF1CC chain in their asymmetric unit. These
assembled into two parallel dimers, each having an ‘open scis-
sor’ conformation that intercalated through their C-terminal
ends to form a palindromic, inverted tetramer (figure 3).
This packing resembles that of the CC domains from the post-
synaptic density protein Homer (PDB code 3CVE), Ndel1
(2V66) and BST2/tetherin (3MKX), although sequence
similarity between these and MuRF1CC is not detectable. In
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Figure 2. Sequence analysis of the HD of MuRFs. (a) Sequence alignment of known MuRF sequences (MuRF1, MuRF2, MuRF3; h ¼ human, m ¼ mouse, r ¼ rat,
b ¼ bovine, p ¼ orangutan). The unstructured acidic tail is excluded. The colour code reflects sequence conservation as identity percentile: dark blue. 80%, light
blue . 60%, light grey . 40%, white  40%. (b) Secondary structure prediction of the HD fraction (lower panel in (a)) of human MuRF1 (grey), MuRF2 (cyan)
and MuRF3 (red). Cylinders indicate helices. (c) Prediction of CC regions in human MuRFs (colour code as above). The total probability for CC formation is shown as a
solid line, with the probability for dimeric CC assembly indicated by a dashed line. Boxed in yellow is the sequence identified here as the CC-compatible segment of
MuRF proteins. Strictly conserved residues are shown in the x-axis.
rsob.royalsocietypublishing.org
Open
Biol.4:130172
3
 on February 27, 2015http://rsob.royalsocietypublishing.org/Downloaded from 
MuRF1, however, the chains within each dimer are out of
registry by one full heptad-repeat and their crossing angle
is broad, leading to the unpairing of both N- and C-termini.
The resulting exposure of hydrophobic residues at the
C-terminus permits the formation of an interchain hydro-
phobic core that supports the assembly of the inverted
tetramer (inset in figure 3). Other than that core, the contacts
within each dimer are few, with only two salt bridges (K224-
E236’ and E236-K238’) providing chain recognition (analysis
of chain interfaces used PISA [31]). One additional salt
bridge (K238-D268’’; chains DA in figure 3a) is present in
the structure, but it contributes to tetramer stabilization.
A further analysis with TWISTER [32] (figure 3b) and
SOCKET [28] (electronic supplementary material, figure S1)
was used to identify stretches in each chain that formed
parallel, antiparallel or simultaneous parallel/antiparallel
interactions. The analysis revealed that MuRF1CC can establish
manifold interactions, being able to support concurrently the
formation of parallel and antiparallel dimers and tetrameric
helical bundles. These promiscuous self-associative interactions
are in agreement with the mixed probability scores of the CC
predictions. This led us to question the prevailing view that
this MuRF1 region associates into robust CC motifs and that
it directs the productive quaternary assembly of MuRF1.
3.3. Coiled-coil fraction of MuRF1 does not assemble
productively in solution
Given the unexpected assembly of MuRF1CC in the crystalline
state, we studied its association in solution using SEC-MALLS.
This technique yields an accurate determination of molecular
mass (MM) without being influenced by molecular shape, an
important consideration when dealing with strongly aniso-
metric molecules. SEC-MALLS measurements yielded an
average MM of 11.8 kDa (table 2; electronic supplementary
material, figure S3a). This value is intermediate between the
calculated MM of a monomer (7 kDa) and a dimer (14 kDa)
of this sample. This indicates that the tetrameric crystalline
state does not predominate in solution, where the sample
appears to form mostly dimers, probably in equilibrium with
a monomeric fraction.
To investigate whether the extraction of MuRF1CC from
its molecular context could have weakened its self-associ-
ation, we assayed next an MuRF1 construct spanning the
full-length of helix H1 (MuRF1H1; figure 1), which probably
constitutes the entire CC motif. The expectation was that
this sample would show a stable, canonical, dimeric associ-
ation. However, SEC-MALLS data revealed that the sample
is trimeric and/or tetrameric in solution (table 2; electronic
supplementary material, figure S3b). The assemblies in sol-
ution may reproduce the interactions observed in the
crystal structure of MuRF1CC, but these might now be stabil-
ized by the longer length of the interacting chain. It can
be concluded that the long helix H1 of MuRF1 does not
assemble into native CC dimers.
3.4. Coiled-coil flanking motifs modulate the formation
of MuRF1 rod-shaped dimers
The irregularities in MuRF1H1 association led us to investigate
the role of CC flanking motifs in assembly. Using SEC-MALLS,
we analysed the oligomeric state of an MuRF1 construct
comprising the full-length helix H1, the preceding B2 box
and the subsequent COS-box (MuRF1B2jCCjCOS; figure 1). The
data (table 2; electronic supplementary material, figure S3c)
showed that the sample forms a range of oligomeric species,
including high-order aggregates, but that a sizeable fraction
forms small assemblies with an average MM of 49.2 kDa.
This value is in excellent agreement with the theoretical MM
of 48.1 kDa for a dimer of this construct, confirming that the
dimer (and not the tetramer) is the ground association state
of this sample.
To explore the global conformational features of
MuRF1B2jCCjCOS, we imaged the dimeric population fraction
using electron microscopy on negatively stained samples
(figure 4a,b). Micrographs showed a rod-like morphology of
approximately 17+3 nm length and 2.6+ 0.36 nm cross-
section (n ¼ 614). This overall shape suggested that, as
expected, the HD forms an elongated shaft with the B2-box
in apical position. However, the molecular length was shorter
than anticipated and could be explained by just the length of
helix H1 (29 helical turns with a pitch of 5.4 A˚ approximates
15.6 nm) plus the B2-box (approx. 2 nm). This led us to infer
Table 1. Diffraction data statistics and model reﬁnement parameters.
space group P21
unit cell dimensions a ¼ 70.79 A˚, b ¼ 24.41 A˚,
c ¼ 75.39 A˚, b ¼ 107.658
X-ray data
beamline I03 (diamond)
detector ADSC Q315r
wavelength (A˚) 0.97
resolution (A˚) 20.00–2.10 (2.15–2.10)
no. unique reﬂections 14 626 (1008)
Rsym (I) 2.7 (45.0)
multiplicity 3.64 (3.74)
completeness (%) 97.7 (99.3)
I/s (I) 17.24 (3.31)
model reﬁnement
no. reﬂections in working/
free set
13 899/725
no. protein residues 228a
no. solvent molecules/buffer
molecules
55/20b
R-factor/R-free (%) 21.18/26.15
RMSD bond length (A˚)/bond
angle (8)
0.006/0.836
Ramachandran statistics
favoured/allowed/outliers (%) 99.07/0.46/0.47
aOut of a total of 244 amino acids, 16 residues were structurally disordered
and are missing from the model (corresponding to 6.5% of the structure).
The missing residues are as follows: chain A (G271), chain C (G-3, E269,
P270, G271), chain B (E269, P270, G271), chain D (G-3, A-2, M-1, D214,
D268, E269, P270, G271).
bOrdered buffer components are glycerol and acetic acid.
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that the two short C-terminal helices (i.e. the COS-box) must
fold against the B2-CC fraction.
3.5. The C-terminal COS-box of MuRF1 is predicted to
have a spectrin-like fold
Next, we explored the fold of the COS-box through ab initio
modelling. This motif has no homology with any protein of
known structure, preventing the application of comparative
modelling. In ab initio modelling, the three-dimensional struc-
ture of proteins is derived from their amino acid sequence by
stitching together suitable protein fragments using simulated
annealing. Themethod is particularly successful when applied
to all-a proteins [33] owing to the greater accuracy of their
secondary structure prediction and the relatively limited
modes of helical packing compared with the variable twists
of b-sheets. Here, we employed the two leading ab initio
modelling programs: QUARK [34] and ROSETTA [35]. QUARK
assembles fragments of variable length identified by fold recog-
nitionmethods. Only available as a server, it returns a set of ten
predictions and estimates of model reliability as TM-scores.
ROSETTA assembles fragments of 3- and 9-residue length ident-
ified using PSI-BLAST. At the fragment assembly stage,
numerous models are clustered by structural similarity and
centroid representatives of large top clusters considered as can-
didate fold predictions. The appearance of a large top cluster is
generally indicative of accurate fold predictions.
First, we modelled the sequence spanning the crystallo-
graphic MuRF1CC and the COS-box, as EM data suggested
that the COS-box might require the preceding MuRF1CC por-
tion for packing. Models calculated using QUARK (figure 5a)
were in excellent agreement with the crystal structure in pre-
dicting MuRF1CC as a long a-helical shaft. They displayed the
C-terminal COS-box as a compact arrangement, where two
short helices folded into an a-hairpin that packed against
the shaft fraction. The resulting three-helix bundle resembled
a minimal version of the spectrin fold, where two helices lie
parallel to each other and the third is a cross-connector [36].
Nine out of the 10 predictions (electronic supplementary
material, figure S2) returned by QUARK shared this same
broad fold and had predicted TM-scores of 0.51–0.45
(over the threshold of 0.3 that indicates statistical signifi-
cance). Ab initio modelling in ROSETTA using the standard
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Figure 3. (a) Crystal structure of MuRF1CC, where helices have been coloured to indicate: no interchain assembly (grey), parallel interaction (beige), antiparallel
interaction (yellow), simultaneous parallel and antiparallel interaction (orange). Salt bridges are labelled. The inset (central panel) shows the hydrophobic core
formation of the tetrameric region. (b) Twister analysis of each MuRF1CC half. The structural point to which the values correspond is indicated by the sequence
(in dimeric or tetrameric state) displayed in the x-axis. Solid lines indicate pitch and dashed lines radius. The pitch and radius vary along the length of the molecule,
but the values of the central region of each dimeric half are close to those of a canonical dimeric CC, where pitch approximates 150 A˚ and radius 5 A˚ [30]. The
analysis of knobs-into-hole packing of each dimer using SOCKET [29] indicated that 18 residues in the AC dimer exhibited a conventional CC packing (7,7,4 repeat),
while the BD dimer had 25 residues in CC arrangement (7,7,7,4 repeat) (electronic supplementary material, figure S1). In the sequence that follows from this,
TWISTER shows the opening of the coil and a resulting helical phase transition (between residues 252-QL-253 in chains A and D, respectively, partnered to
chains C and B at motif 259-LV-260; highlighted by a red box) that defines the switch from a dimeric to a tetrameric association.
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protocol was unsuccessful, with the program overriding long
helices suggested by secondary structure predictions to pro-
duce compact, globular folds. This is a known limitation of
ROSETTA when handling anisometric structures [33]. Thus,
we next provided ROSETTA with the crystal structure of
MuRF1CC as a fixed fraction. This resulted in the largest clus-
ter containing 150 of the total 1000 models, indicative of a
satisfactory result (figure 5b). The model shared the same
topology with QUARK models (electronic supplementary
material, figure S2d ), this consistency being a further
indication of reliable modelling.
We then performed ab initio modelling in QUARK of the full-
length HD of MuRF1, comprising helix H1 and COS-box
(MuRF1HD). The models (figure 5c) represented the N-terminal
fraction of the domain as a single uninterrupted helix and were
consistent with those of MuRF1CC plus COS-box described
above. This result is in excellent agreement with secondary
structure predictions (figure 2) and EM data.
Interestingly, a comparison of ab initio models with the
crystal structure of MuRF1CC revealed a remarkable simi-
larity in helix packing (electronic supplementary material,
figure S4). In the MuRF1CC tetramer, helices arrange them-
selves along the same interfaces as those occupied by the
COS-box a-hairpin in the ab initio models. This suggested
that the crystallographic arrangement was a compensatory
conformation aimed to satisfy naturalistic interfaces.
Finally, we sought validation of the ab initio models by
testing the interaction of independently produced samples
of MuRF1H1 and the COS-box a-hairpin (MuRF1COS). Co-seg-
regation of both samples in size-exclusion chromatography
(figure 4c; electronic supplementary material, figure S5)
confirmed the interaction of the two segments. Our earlier
work [11,29] showed the HD of MuRF1 (spanning H1 and
COS-box) to be dimeric, similar to MuRF1B2jCCjCOS in this
work. However, individually MuRFH1 forms higher assem-
blies (table 2). This led us to conclude that the interaction of
H1 and COS-box prevents the non-native association of the
HD, and thus that the COS-box is required to achieve
productive homodimerization.
3.6. In vivo expressed COS-box targets sarcomeric
structures similar to full-length MuRF1
We testedwhether the COS-box contributes to sortingMuRF1 to
its in vivo locations. For this,we first confirmed the localization of
endogenous MuRF1 by immunostaining (figure 6a–c). This
detected MuRF1 mostly in the Z-disc (consistent with its
interaction with Z-disc proteins [20,21]) and also, more discre-
tely, in the M-line region (consistent with its binding to titin
A168–170 [11,12]) (figure 6a–c). Endogenous MuRF1 is also
known to localize to the neuromuscular junction [37]. Then,
we transfected the tibialis anterior (TA) muscle of adult mice
with a COS-GFP fragment. In vivo imaging of the overexpressed
COS-box showed a regular pattern of striations in the myofibril,
indicative of its targeting of defined sarcomeric structures
(figure 6d,e). In addition, GFP fluorescence was also present in
punctate structures co-localizing with endocytic acetylcholine
receptor at the neuromuscular junction (figure 6f,g). To deter-
mine the precise localization of COS-GFP in the sarcomeric
striations, sections of the imaged muscles were prepared and
stained against f-actin using the marker phalloidin-TRITC
(figure 6h). This assigned the predominant in vivo targeting of
COS-GFP to the Z-line/I-band region. The fainter binding at
the M-line was no longer detectable, probably having been
disrupted by the fixation procedure. On the whole, these data
indicate that the localization of COS-GFP is consistent with
that of endogenous MuRF1. Furthermore, the findings comp-
lement a recent study on a pathogenic mutation of MuRF1,
Q247*, linked to hypertrophic cardiomyopathy [38]. The
mutation results in a truncated protein that lacks the COS-box.
Truncated MuRF1 remains diffuse in the cytoplasm, no longer
targeting sarcomeric structures and with a near-total loss of
ubiquitinating function. It can be concluded that the COS-box
is an important mediator of MuRF1 interactions in vivo, and
that it is necessary and sufficient for the recruitment of MuRF1
to the sarcomeric cytoskeleton.
4. Discussion
CC domains are thought to drive the organization of TRIM
proteins into functional assemblies. However, our analysis
of the CC from MuRF1 (MuRF1CC and MuRF1H1) suggests
that this domain does not govern molecular order in this
TRIM but that flanking domains modulate its associative
function. It is not rare that CC domains extracted from their
protein context no longer assemble natively. For example,
the coil 2 from lamin A forms parallel dimers in its intermedi-
ate filament context, but antiparallel dimers in isolation [39].
To compensate for the promiscuity of the CC fold, many
CC-containing proteins have additional motifs that condition
the self-assembly of these domains. An example is the
dimeric dystrophia myotonica protein kinase (DMPK),
whose C-terminal CC domain forms robust, but artefactual,
trimers in isolation [40]. DMPK assembles into functional
homodimers by means of an N-terminal association motif
that dictates the subsequent interaction of the CC fraction
[41]. In MuRF1, the B2- and COS-boxes flanking helix H1
act as terminal clamps that secure the correct self-assembly
of the CC. Our previous structural characterization of the
MuRF1 B2-box showed that it forms homodimers in solution
with high affinity [29]. Studies on other TRIM proteins have
confirmed that B-boxes also form homodimers in those cases
[42]. Thus, our data explain the need for the B2-box to pre-
cede and pre-define the chain registry of the CC domain so
as to initiate its productive assembly by vicinal confinement.
This provides a rationale for the universal presence in the
TRIM fold of the B2 box immediately N-terminal to the CC
motif, forming an evolutionarily conserved core unit. Here,
we also show that at the C-terminus, CC and COS-box
Table 2. SEC-MALLS measurements. MM calculated from sequence data
(MMcalc) is quoted for the monomeric chain, with the value for a dimer given
in brackets. Experimental MM values (MMexp) have been measured using
SEC-MALLS (data shown in the electronic supplementary material, ﬁgure S3).
CC214– 271 H1169– 263 B2jCCjCOS114–327 aHD166– 327
MMcalc (kDa) 7 (14) 11.3 (22.6) 24 (48.1) 17.4 (34.7)
MMexp (kDa) 11.8 37.4 49.2 32.3
aGiven here for comparison, values reported in [28] for the full-length HD
of MuRF1 spanning H1 and COS regions.
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sequences are integrated into a structural unit, together form-
ing an HD, where the COS-box might prevent fraying of the
CC and aid the formation of functional dimers. This is the
first example of how a specific C-terminal domain is inte-
grated within the conserved TRIM fold to modulate its
structure and function. We anticipate that this architectural
design is shared by all 10 TRIMs in classes I–III where the
CC is immediately followed by a COS-box [5]. In addition
to the close MuRF1 homologues MuRF2 and MuRF3, these
classes include proteins such as the Opitz syndrome protein
Midline-1 (MID1) and its homologue Midline-2 (MID2), the
brain-specific TRIM9 that is seemingly linked to neuronal
dysfunction in dementia, and Harprin (TRIM36), thought to
regulate the acrosome reaction in sperm during fertilization.
We predict that the COS-box has a minimalistic spectrin-
like fold. The spectrin fold has been particularly observed in
microtubule-associated proteins [36], consistent with the role
attributed to the COS-box [7,14]. The mutation of the con-
served motifs FLQ and LDY in the COS-box of MID1
(respectively, 275-FLL-277 and 323-IDF-325 in MuRF1)
were shown to independently abolish the interaction with
microtubules [7]. Ab initio models in this study indicate
that these motifs co-localize at the termini of the COS a-
hairpin, at the base of the HD (figure 5a). This suggests
that these motifs are important for the correct folding of
the COS-box and/or that they form a key interaction locus
in the fold. Furthermore, previous SPOT-blots identified a
C-terminal sequence as the primary interaction site of
MuRF1 with M-line titin [20]. The mapping of this sequence
on our secondary structure predictions (figure 2) and on
the ab initio models (figure 5) shows that it corresponds to
helix H3. This helix is in the outermost position in the
models and thus is largely accessible. We conclude that
our model of MuRF1 COS-box rationalizes current binding
data on this motif. Finally, we summarize the findings
from this study in the proposal of an overall structural
model of MuRF1 (figure 4d ) that might guide its further
functional study.
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Figure 4. Characterization of MuRF1B2jCCjCOS. (a) Electron micrograph of negatively stained MuRF1B2jCCjCOS samples corresponding to the outermost tail fractions of size-
exclusion chromatograms containing dimeric assemblies (electronic supplementary material, figure S3). (b) Gallery of three major class averages obtained by using the
processing software EMAN1. (c) Complexation of MuRF1H1 and MuRF1COS samples monitored by size-exclusion chromatography. The complex was formed by mixing the
samples in a molar ratio of 1 : 2.5 in 20 mM Tris–HCl pH 7.5, 200 mM NaCl, 1 mM DTT followed by incubation for 1 h at 48C. The mixture was run on a Superdex 200
HiLoad 26/60 column. Chromatogram and associated SDS-PAGE are shown. MW marker is SeeBlue Plus2 Pre-stained standard (Invitrogen) (samples are proximal to the
6 kDa band). (d ) Proposed quaternary structure of MuRF1 compiling known and predicted structural information on MuRF1. The structure of the B2-box dimer is that
previously elucidated by X-ray crystallography (PDB 3DDT) [29]; the model for the HD and its dimeric assembly is as deducted in the current study.
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5. Conclusion
The change in demographics and inactive lifestyles is making
muscle loss an endemic problem in the populations of devel-
oped countries. Hence, the study of pathways that regulate
the degradation of muscle proteins is of high interest. Over
50 potential MuRF1 targets have been proposed based on
yeast two hybrid screens, including sarcomeric proteins of
the Z-disc and M-lines [20,21], and the neuromuscular junction
[37]. Our findings suggest that the COS-box is a region of high
structural and functional importance in MuRF1. It is a necess-
ary interaction motif that mediates MuRF1 recruitment to
myocellular structures, and thus the pharmacological pertur-
bation of its targeting might open new avenues for the
control of MuRF1-mediated atrophy of the myofibril.
6. Methods
6.1. Sequence analysis
Sequences of MuRF proteins were obtained from the Uni-
protKB database and aligned with CLUSTALW2 [43] using the
BLOSUM matrix. Secondary structure predictions of the heli-
cal regions of MuRF1, -2, -3 used Jpred3 [44]. The probability
for CC formation was calculated with MULTICOIL [45] using a
sequence window of 28 residues.
6.2. Cloning
Human MuRF1CC (UniProtKB Q969Q1) was cloned into the
vector pETM-11 (EMBL collection) using KpnI and NcoI restric-
tion sites. This vector incorporates a His6-tag and a TEV
protease cleavage site N-terminal to the target construct.
MuRF1H1 (containing the mutation C173S) was cloned into
pETM-20 (EMBL collection) using the restriction sites NcoI
and BamHI, fusing an N-terminal His6-TRX tag to the target
construct, cleavable by TEV protease. MuRF1COS was cloned
into the NcoI and Acc65I sites of pETZZ (http://babel.ucmp.
umu.se/cpep/web_content/Pages/CPEP_09_vectors.html) to
produce a TEV-protease-cleavable N-terminal His6-ZZtag con-
struct. The expression clone of MuRF1B2jCCjCOS (containing
the mutation C298S) has been previously reported [29].
The C-terminal fusion of the COS-box to GFP was
obtained by cloning MuRF1COS into the pEGFP-N1 vector
using XhoI and EcoRI sites.
All constructs were verified by sequencing (Geneservice).
6.3. Protein production
MuRF1 samples were overexpressed in Escherichia coli Rosetta2
(DE3) or BL21 (DE3) (Novagen). Cultures were grown at 308C
up to an OD600 of 0.6 in Luria Bertani medium supplemented
with 20 mg ml21 chloramphenicol and 30 mg ml21 kanamycin.
Expression was induced by 0.75 mM isopropyl-b-D-thiogalac-
topyranoside (IPTG) and cultures were grown for a further
20 h at 208C. Cells were harvested by centrifugation at 48C.
Bacterial pellet was resuspended in lysis buffer (50 mM Tris
pH 8.0, 50 mM NaCl, 0.5 mM b-mercaptoethanol) containing
a protease inhibitor cocktail (Roche). Lysis was carried out
by French pressing in the presence of DNAse. The homogenate
was clarified by centrifugation and the supernatant applied to
a Ni2þ-chelating His trap column (GE Healthcare) equilibrated
in lysis buffer containing 20 mM imidazol. Elution used
200 mM imidazol. Tag removal was by incubation with TEV
Q247*
275-FLL
323-IDF
N
(a) (b)
C
H1
H2
H3
(c)
Figure 5. Ab initio modelling of MuRF1 COS-box. (a) Top QUARK model spanning MuRF1CC plus the subsequent COS-box region coloured in a blue-to-red gradient.
The model is superimposed on the crystal structure of MuRF1CC (grey). The pathogenic Q247* mutation is shown in black and motifs previously identified to mediate
microtubule binding in protein MID1 are in magenta [7]. Additional QUARK models are shown in the electronic supplementary material, figure S2. (b) ROSETTA-
calculated model of the same segment derived from a cluster of 150 models. A comparison of QUARK and ROSETTA models is shown in the electronic supplementary
material, figure S2. (c) Top QUARK model of the full-length HD of MuRF1 (the degree of bending of the long helix H1 is not meaningful).
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protease overnight at 48C during dialysis against lysis buffer.
The protein was then subjected to subtractive metal affinity
chromatography followed by gel filtration on a Superdex 75
16/60 HL column or on a Superdex 200 26/60 HL column
equilibrated in 20 mM Tris pH 7.5, 200 mM NaCl (GE Health-
care). The purified sample was stored at 48C until further use.
The production of MuRF1B2jCCjCOS was as reported [29].
6.4. Crystal structure elucidation
Crystals were grown at 208C in hanging drops using 48-well
plates (Hampton Research). Drops consisted of 1 ml protein
solution at 14 mg ml21 and 1 ml mother liquor containing
35% MPD, 0.1 M sodium acetate pH 4.5, 20% [v/v] glycerol
and 20 mM NaF. Crystals grew as thin plates with dimen-
sions of 400  100 m2 in the measurable plane of the plate.
For X-ray data collection crystals were flash frozen in liquid
nitrogen. X-ray diffraction data were processed with XDS/
XSCALE [46] (table 1). Crystals contained four MuRF1CC
chains in the asymmetric unit, corresponding to a solvent
content of 46%. Analysis with POLARRFN revealed a two-
fold (k ¼ 1808) non-crystallographic axis contained within
the crystallographic ac plane (v ¼ 908, f ¼ 1538). Phases
were obtained using ARCIMBOLDO [47]. Subsequent
(h)
0
50 mm
50 mm 10 mm
phalloidin-TRITC
MuRF1-
COS-GFP
4 8
distance (mm)
16 20 24
(a)
(b)
(c)
(d)
( f )
(g)
(e)
Figure 6. MuRF1 COS-box targeting of myocellular structures in vivo. (a– c) Localization of endogenous MuRF1 within sarcomeres. Muscle tissues were dissected
from mice 5 days post-denervation, single myofibrils prepared from M. gastrocnemius and immunostained for (a) MuRF1 or (b) desmin. A merge of (a) and (b)
indicates that endogenous MuRF1 under muscle stress targets predominantly (c) the Z-disc region and to a lesser extent the M-line. (d–g) In vivo targeting of
transiently expressed MuRF1 COS-GFP fusion protein in transfected skeletal muscle. Depicted is (d,e) the enrichment of COS-GFP in sarcomeric striations as well as
( f,g) an enrichment in puncta containing endocytic AChR (( f ) a-bungarotoxin staining; (g) COS-GFP; arrowheads mark COS puncta that are also positive for AChR).
A negative control corresponding to transfected GFP alone is shown in the electronic supplementary material, figure S6. (h) After fixation and staining with phalloidin-
TRITC against f-actin, longitudinal sections of the muscles depicted in (d–g) show enrichment of COS-GFP in the Z-line/I-band, mimicking the distribution of endogenous
MuRF1. Faint immunopositive signal on the M-line (a) is also present with COS-GFP in vivo (e) but does not stand fixation and staining (h).
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model building used COOT [48] and ARP/wARP [49], while
refinement was in PHENIX [50]. Building of solvent and
ordered buffer components used PHENIX and COOT.
6.5. Multi-angle laser light scattering
Measurements were performed on a Dionex BioLC HPLC
connected to an 18-angle light-scattering detector and a differ-
ential refractometer (DAWN HELEOS-II and Optilab rEX,
Wyatt). A Superdex 75 10/300 GL column (GE Healthcare)
was used in 20 mM Tris pH 8.0, 50 mM NaCl at a flow rate
of 0.75 ml min21. Sample volumes of 1 ml were injected at a
concentration of 1.5 mg ml21. Samples eluting from the
column passed through an in-line DAWN HELEOS-II laser
photometer (l ¼ 658 nm) and an Optilab rEX refractometer
with a QELS dynamic light-scattering attachment. Light-
scattering intensity and eluent refractive index (concentration)
were analysed using ASTRA v. 5.3.4.13 software to give a
weight-averaged MM. To determine the detector delay
volumes and normalization coefficients for the MALLS
detector, a BSA sample (Sigma A-8531) was used as reference.
The SEC-MALLS analysis of MuRF1B2jCCjCOS samples
was carried out as above but used a Superdex 200 10/300
prep-grade column equilibrated in 20 mM Tris pH 8.0,
100 mM NaCl. MuRF1B2jCCjCOS was injected at 0.7 mg ml21.
6.6. Transmission electron microscopy and image
processing
Aliquots of 5 ml sample were adsorbed onto a glow-
discharged carbon film-coated copper grid, washed with
three droplets of pure water and subsequently stained with
2% uranyl-acetate. Images were recorded using a Philips
CM10 TEM (The Netherlands) operating at 80 kV on a
Veleta 4 k CCD camera (Olympus, Germany).
Reference-free alignment was performed on manually
selected particles from electron micrographs using the
EMAN image-processing package [51]. Next, particle projec-
tions were classified by multi-variant statistical analysis. The
class averages with the best signal-to-noise ratio were selected
and gathered in a gallery.
6.7. Ab initio modelling
The MuRF1 sequence corresponding to residues 214–327 was
submitted to the QUARK ab initiomodelling server [34]. For com-
parison, fragment assembly-based ab initiomodelling was done
with ROSETTA using default parameters (ab initio protocol) to pro-
duce 1000 models [35]. This was done both with and without
specifying that residues 214–271must adopt the experimentally
determined helical structure (flag fix_residues_to_).
6.8. In vivo transfection, staining and imaging
For the analysis of endogenous MuRF1 distribution in TA, its
expression was induced by two weeks of N. ischiadicus
denervation. Single myofibrils from TA were prepared as
before [52], and endogenous MuRF1 was detected with
three different polyclonal antibodies [21,37] (available from
www.myomedix.com). Double labelling with desmin,
coupled to AlexaFluor647, was used to determine Z-disc
localized MuRF1 epitopes. All staining was done using stan-
dard protocols as previously described [53].
Expression of MuRF1COS fused C-terminally to EGFP was
by transfection of the expression vector into TAmuscles, as pre-
viously described [54]. Ten days post-transfection, mice were
anaesthetized, transfected muscles exposed and injected with
the marker for acetylcholine receptors, a-bungarotoxin-Alexa-
Fluor647, as previously described [37]. Mice were then
transferred to a confocal microscope (DMRE TCS SP2, Leica
Microsystems) and GFP fluorescence excited using a KrAr
laser (488 nm). Emission was detected by a 63x/1.2NA HCX
PL APO CS W CORR objective (Leica Microsystems) (immer-
sion medium Visc-Ophtal gel, Winzer-Pharma) using 500–
550 nm bandpass. Next, muscles were extracted and fixed in
4% PFA/PBS overnight at 48C, washed in PBS for 30 min
and embedded in 2% agarose. Longitudinal slices of 50 mm
thicknessweremadeusinga LeicavibratomeVT1000 S, permea-
bilized for 4–5 h in 0.1% Triton X-100 and washed in PBS.
Sarcomeric actin was labelled with 250 nM phalloidin-TRITC
(Life Technologies) in 2% BSA/PBS overnight; slices were then
washed in 2% BSA/PBS for 1–2 h and embedded in Mowiol.
GFP, phalloidin-TRITC and a-bungarotoxin-AlexaFluor647
were excited at 488, 561 and 633 nm, respectively. Emission
was detected at 500–550, 570–620 and 650–750 nm bandpass.
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